David Abramson

Chief, Ophthalmic Oncology

Memorial Sloan Kettering Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Abramson is the Chief of Ophthalmic Oncology at Memorial Sloan Kettering Cancer Center in the United States. His research focuses on retinoblastoma, including innovative treatment approaches such as high-dose topotecan and ophthalmic artery chemosurgery. He has also published work on the implications of histiocytosis in ocular health and the utility of machine learning in diagnosing retinoblastoma.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (1)

Robert G. Maki

Professor, Member

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Abramson

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

High-dose topotecan (90 and 180 μG) for recurrent subretinal and vitreous seeding in retinoblastoma

Ophthalmic Artery Chemosurgery for Retinoblastoma Babies Less than 3 Months Old or under 6-kg Weight

Subfoveal Choroidal Thickness in Patients with Histiocytosis and Multimodal Imaging Features of Choroidal Infiltrates

Vitreoretinal lymphoma: the importance of cerebral spinal fluid evaluation at initial diagnosis

Machine learning demonstrates clinical utility in distinguishing retinoblastoma from pseudo retinoblastoma with RetCam images

The Impact of Li-Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations

Ocular findings in patients with histiocytosis and association with clinical and molecular features

What have we learned about intraarterial chemotherapy (Ophthalmic Artery Chemosurgery) for retinoblastoma in the past 18 years? The third A. Linn Murphree Lecture

Histiocytosis of the orbit and its association with KRAS mutations

Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving Histiocytosis

Collaborators (1)

Robert G. Maki

Make your next move.